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Abstract
Background: Major depressive disorder (MDD) shows large heterogeneity of symptoms between patients, but
within patients, particular symptom clusters may show similar trajectories. While symptom clusters and networks
have mostly been studied using cross-sectional designs, temporal dynamics of symptoms within patients may yield
information that facilitates personalized medicine. Here, we aim to cluster depressive symptom dynamics through
dynamic time warping (DTW) analysis.
Methods: The 17-item Hamilton Rating Scale for Depression (HRSD-17) was administered every 2 weeks for a
median of 11 weeks in 255 depressed inpatients. The DTW analysis modeled the temporal dynamics of each pair of
individual HRSD-17 items within each patient (i.e., 69,360 calculated “DTW distances”). Subsequently, hierarchical
clustering and network models were estimated based on similarities in symptom dynamics both within each
patient and at the group level.
Results: The sample had a mean age of 51 (SD 15.4), and 64.7% were female. Clusters and networks based on
symptom dynamics markedly differed across patients. At the group level, five dynamic symptom clusters emerged,
which differed from a previously published cross-sectional network. Patients who showed treatment response or
remission had the shortest average DTW distance, indicating denser networks with more synchronous symptom
trajectories.
Conclusions: Symptom dynamics over time can be clustered and visualized using DTW. DTW represents a promising
new approach for studying symptom dynamics with the potential to facilitate personalized psychiatric care.
Keywords: Major depressive disorder, Routine outcome monitoring, Cluster analysis, Symptom dynamics, Inter-
individual variation, Intra-individual variation, Symptom trajectories
Background
Depression is defined by its symptoms (such as a sad
mood and insomnia) that are correlated with each other.
The dominant explanation in the field has been that
these relations stem from a shared causal origin, a
perspective termed the common cause framework [1, 2].
The contemporary conceptualization for major depres-
sive disorder (MDD) is similar to that of other medical
conditions in that it assumes all observable depressive
symptoms are caused by an underlying disease construct
[1, 3]. In research, symptoms are usually added up to
sum scores, and thresholds are used to indicate case sta-
tus. This approach assumes that symptoms are equiva-
lent, causally independent, and roughly interchangeable
indicators of the underlying disease construct [4]. This
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conceptual framework has dominated depression re-
search over the past decades: the inclusion criteria in re-
search studies were based on the syndromal DSM
diagnoses of MDD, and the unweighted sum scores of
depression rating scales were used as a measure for se-
verity and treatment response [5] (e.g., Hamilton Rating
Scale for Depression [HRSD] [6] and Montgomery-
Åsberg Depression Rating Scale [MADRS]) [7]. How-
ever, years of research have shown slow progress in the
search for the underlying risk factors and biomarkers of
the unitary construct MDD [4]. The need for a new, sci-
entifically sound approach for conceptualizing depres-
sion is warranted.
Increasing evidence points towards the multidimen-
sional character of MDD with a high degree of symp-
tomatic variability between and within patients [4, 8].
Individual symptoms are mutually interacting and caus-
ing each other [9], and they have different risk factors
[10, 11], underlying biology [11–13], psychosocial im-
pact [14], and course trajectories [5]. Recent years have
therefore seen a shift in the conceptualization of de-
pression towards a network perspective where the de-
pressive syndrome is hypothesized to stem from mutual
causal relations among components of the system, such
as depression symptoms [9, 15]. Furthermore, patients
manifest specific depression symptom profiles with
preferential responses to different treatments. Conse-
quently, there is increasing recognition of the import-
ance of investigating individual symptoms and their
timely evolution, both within individual patients and in
groups of patients [16, 17]. This is also in line with the
aims of the Research Domain Criteria (RDoC) project
to deconstruct psychiatric disorders by analyzing the
dynamics (e.g., symptom trajectories over time) that lie
at their basis [18, 19].
Several factor analytic studies of the HRSD-17 have
tried to tackle the symptomatic diversity of MDD by
means of identifying homogeneous symptom groups
within MDD. Although there was evidence for a “general
depression” and “insomnia” factor, the overall results
were inconsistent, with reported factors ranging from
two to eight [20–23]. Furthermore, factors seemed to
change over time [24] and were poorly generalizable to
other populations. Hierarchical cluster analysis is another
statistical method to decompose MDD into homogeneous
symptom groups, and comparable results (“general depres-
sion,” “insomnia”) have been found with this approach [25,
26]. Network analysis is a more recent approach that
expands further on studying the symptom correlations by
investigating the influence of symptoms on each other [9].
Both factor and network analyses were mostly conducted
on cross-sectional data, and consequently, they did not
take the temporal dynamics of symptoms into account.
Furthermore, both techniques almost exclusively studied
aggregated patient data without studying the intra-
individual symptom heterogeneity.
Routine outcome monitoring (ROM) entails the col-
lection of clinical data at baseline and at regular time in-
tervals thereafter in order to monitor disease severity as
well as the clinical course during treatment. ROM may
provide feedback to both the clinician and the patient
and enable “patient-centered research” [27, 28]. Time-
series ROM data enable the capturing of dynamics of
symptoms over time using dynamic time warping (DTW).
DTW is a widely used statistical algorithm [29, 30],
though not yet in psychological and psychiatric research.
It is an effective clustering strategy for time-series data
across a broad range of application domains [31]. Exam-
ples of biomedical applications are speech recognition
[16], gait pathology [32–34], and electro-cardiogram ana-
lysis [35]. The DTW approach could be well-suited to
cluster individual symptoms based on the temporal fea-
tures that they share, using ROM or ecological moment-
ary assessment EMA [36] time-series data.
In this study, we utilize depression symptom data from
a clinical ROM regime, every 2 weeks, of 255 depressed
inpatients and present the first implementation of DTW
time-series analysis on depression symptom trajectories.
This paper is built upon a dual structure in which the
DTW analysis is introduced both for intra-individual
(i.e., idiographic) and inter-individual (i.e., nomothetic)
analysis [37]. In the idiographic analysis, we aim to as-
sess the dynamics and covariation of changes in symp-
toms over time within each individual patient with two
or more assessments and to estimate the symptom clus-
ters and networks within each patient. In the nomothetic
analysis, we aim to study the aggregated dynamics of in-




From the original study sample of 276 consecutive pa-
tients (i.e., included in the cohort study in the order that
they were admitted), 21 patients had only one HRSD-17
measurement due to a short hospitalization period or re-
fusal to participate, yielding 255 (91.6%) patients in-
cluded in the current analysis. Thus, we included 255
adult patients consecutively admitted to a tertiary psy-
chiatric hospital in Duffel, Belgium, and fulfilling the
MINI-Plus diagnosis, based on the DSM-IV criteria, of a
depressive episode as part of an MDD or bipolar dis-
order (BD). In order to obtain a representative sample of
depressed participants, exclusion criteria were minimal.
We did not include patients with (comorbid MINI-Plus)
psychotic disorders (including schizoaffective disorder)
or with a dependency on alcohol or drugs within 12
months prior to hospitalization. Moreover, patients with
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insufficient mastery of the Dutch language were not
included.
Treatment
Inpatients received treatment as usual which was based
on evidence-based guidelines and consisted of pharma-
cotherapy, (group) psychotherapy, or a combination of
both. These guidelines for diagnosis and treatment were
formulated by the Dutch Association of Psychiatry, often
in association with the associations of psychology and
general practitioners (www.trimbos.nl, www.nvvp.net).
Psychotropic medication at baseline was coded into five
dichotomous variables: antidepressants, mood stabilizers,
antipsychotics, benzodiazepines, and stimulants. Re-
sponse was defined as a ≥ 50% reduction of the HRSD-
17 compared to the baseline assessment. Remission was
defined as scoring ≤ 7 on the HRSD-17.
Measurements
The present study was part of a larger follow-up study
investigating the feasibility of ROM in the University
Psychiatric Centre in Duffel [38]. ROM were done at
baseline and every 2 weeks thereafter during the clinical
admission which lasted from 2 weeks to 16months.
ROM consisted of a test battery assessing overall mental
well-being, quality of life, and mood (including the
Hamilton Depression Rating Scale-17). The data pre-
sented in this article represent the collected data from
the period April 2015 through February 2018.
The HRSD-17 consists of 17 items on a Likert scale,
ranging from either 0 to 4 (for 9 items) or 0 to 2 (for 8
items). The internal reliability of the HRSD-17 is ad-
equate with most studies reporting a Cronbach’s alpha
of ≥ 0.70. It has a good retest and interrater reliability
(above 0.80) when assessed over an interval ranging
from 1 to 30 days [21]. The Omega and Cronbach’s
alpha in our sample of 255 patients at baseline were only
0.49 and 0.52, respectively. The Cronbach’s alpha im-
proved over time with a score of 0.74 after 2, 0.77 after
4, and 0.79 after 6 weeks. The total score ranges from 0
to 52, and higher scores indicate greater severity, but in
the present study, we focus on the trajectories of the 17
individual items only. In order to improve interrater reli-
ability, Hamilton Depression Rating Scale training ses-
sions were organized every 3 months among the in total
6 assessors, during which video-recorded interviews with
patients were rated and discussed to reach consensus. In
total, they conducted 1480 HRSD-17 assessments in 255
patients, with an average of 5.8 assessments per patient.
Statistical analysis
DTW is an approximate pattern detection algorithm that
can measure the similarity between two time-series. It
uses a dynamic (i.e., stretching and compressing)
programming approach to minimize a predefined dis-
tance measure (e.g., Euclidean distance), in order for the
two time-series to become optimally aligned through a
warping path. The “optimal” alignment minimizes the
sum of distances between the aligned elements. The
“dtw” (version 1.20.1), “pheatmap” (version 1.0.12), “par-
allelDist” (version 0.2.4), and “qgraph” (version 1.6.2)
packages for the R statistical software were used (R ver-
sion 3.6.0; R Foundation for Statistical Computing,
Vienna, Austria, 2016. URL: https://www.R-project.org/).
The idiographic approach per patient was followed by
a nomothetic approach to study the depression symptom
patterns both within individual patients and in the whole
sample of 255 patients. The subsequent methodological
steps and statistical methods are described below.
Intra-individual approach
We first aimed to cluster individual symptoms based on
the temporal features that they share within each indi-
vidual patient. The clustering of symptom trajectories
based on DTW consisted of two steps. First, the DTW
distance between each pair of symptom trajectories was
calculated. This is illustrated in Fig. 1 with the example
of two HRSD-17 item time-series (item 1 “depressed
mood” and item 7 “work and interest”) of a single pa-
tient. The temporal scoring (per 2 weeks) on the given
items is seen in Fig. 1a, with the two items for which the
DTW distance is calculated shown in red. This patient
had 14 assessments over a period of 26 weeks. The tra-
jectories of items 1 “depressed mood” and 7 “work and
interest” over time are plotted in Fig. 1b. The deforma-
tions of the time axes between both items are added,
which brings the two time-series as close as possible to
each other, in which all elements must be matched.
Next, the calculation of the shortest path between the
two time-series is shown in Fig. 1c. The two time-series
were aligned in time with compressions and expansions.
The “symmetricP0” step pattern was used as the dy-
namic time warping algorithm to match the two se-
quences, resulting in the red “warping path.” A Sakoe-
Chiba Band of 2 was used in order for the severity scores
to be matched to a maximum of plus or minus two time
points (plus or minus a maximum of 4 weeks). Resulting
from the DTW method, a distance measure (d) is pro-
duced: items with the best alignment, having a more
similar slope and other dynamics (i.e., changes that co-
vary over time), resulted in the smallest distance. The
distance measures of each of the 17 time-series of indi-
vidual HRSD-17 items are grouped in a distance matrix,
comprising (172 − 17)/2 = 136 distances for each individ-
ual patient.
Second, this matrix of 136 distances was presented in
a heatmap and used in a hierarchical cluster analysis and
a symptom network per patient. For the hierarchical
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cluster analysis, each item is initially assigned to its own
cluster, and then the algorithm proceeds iteratively, at
each stage joining the two most similar clusters, con-
tinuing until there is just a single cluster. We assumed 3
clusters for each patient, for illustrative purposes only,
to enable easier recognition of the symptom with the
more similar trajectories. We excluded all symptoms
with a score of 0 throughout follow-up, as these tended
to cluster together most strongly as these symptom pairs
will have a distance of 0. At each stage, distances be-
tween clusters are recomputed by the Lance-Williams
dissimilarity update formula according to the “Ward.D2”
clustering methods. With “Ward.D2,” the total within-
cluster variance is minimized, and the dissimilarities are
squared before cluster updating.
Using the “qgraph” package, the structure of the net-
work based on the distance matrix was visualized per pa-
tient, providing another way of graphical presentation of
the clusters. We followed the recommendations on net-
work analysis written by the developers of the R package
[39]. A network with up to 17 nodes (representing the
individual HRSD-17 depression symptoms) is obtained
and, connecting them, the edges representing the dis-
tances between symptom trajectories. The thickness of
the edges indicates the strength of the longitudinal elas-
tic covariation (thicker edges represent a shorter dis-
tance between the two symptom trajectories).
Inter-individual approach
Next, we aimed to study the aggregated dynamics of in-
dividual symptoms to yield systematic patterns over time
across patients. In this second part, we aimed to build a
generalizable hierarchy of symptom clusters based on
their shared temporal features. First, the 136 distances
were averaged over the 255 patients, weighted for the
number of assessments that were done for each of the
patients (ranging from 2 through 17). Second, this
matrix of 255 mean distances was used for the
generalizable hierarchical cluster analysis. A scree plot
was constructed displaying the heights in a downward
curve and the elbow rule (i.e., the point where the graph
leveled off) was used to determine the most appropriate
number of clusters.
The “Distatis” algorithm from the “DistatisR” package
was used to check whether using the actual 255 distance
matrices instead of one mean distance matrix yielded
similar clusters. Distatis is a generalization of classical
multidimensional scaling (MDS), based on a three-way
principal component analysis, to analyze a set of distance
matrices. In order to compare these distance matrices, it
combines them into a common structure called a com-
promise and then projects the original distance matrices
onto this compromise. Compromise factors are calcu-
lated and plotted in the compromise space, with each
component been given the length corresponding to its
eigenvalues. We plotted each of the 17 HRSD symptoms
on an X-Y plane according to their first and second
compromise factor values.
In the following step, we investigated two centrality
metrics, being closeness centrality and degree centrality
[40] for the average distance matrix. Degree centrality is
based on the number and strengths of connections each
symptom has. Closeness centrality also takes the global
network structure into account because it measures the
average distance of a certain symptom to all other symp-
toms. Applied on the DTW data, closeness is inversely
proportional to the mean DTW to all other symptoms
and, in this way, indicates which symptom trajectory is
the most similar to that of other symptoms.
Finally, we computed the average DTW distance among
all symptom trajectories for each patient. Symptoms that
scored consistently zero were deleted from these analyses
for that particular patient, as all such symptoms would re-
sult in distances of zero. Shorter average DTW distances
reflected denser interconnections between symptoms, and
longer average DTW distances reflected looser longitu-
dinal connectivity between symptoms. In order to investi-
gate the relationship between network density and
reaching response and remission, we calculated the resid-
uals of the regression with the number of assessments and
the HDRS sum score. These residuals were plotted using
box plots according to whether response and remission
were reached, and we performed Wilcoxon signed-rank
tests to compare the two samples.
The analyses used the packages “dtw” (version 1.20.1),
“pheatmap” (version 1.0.12), “parallelDist” (version
0.2.4), “qgraph” (version 1.6.2), and “DistatisR” (version)
for the R statistical software (R version 3.6.0; R Founda-
tion for Statistical Computing, Vienna, Austria, 2016). A
sample code (with data from the of 2 exemplar patients
of Fig. 2) can be found in Additional file 1.
Results
Patient characteristics
Table 1 shows the demographic and clinical characteris-
tics and the use of psychotropic medication of the
(See figure on previous page.)
Fig. 1 For a single patient, the individual HRSD-17 item scores over time are shown (a). The DTW method uses a dynamic (i.e., stretching and
compressing) programming approach to minimize a predefined distance measure (e.g., Euclidean distance), in order for the two time-series to
become optimally aligned through a warping path (b). The optimal warping route between items 1 and 7 is shown (c). Using the “symmetricP0”
step pattern and a Sakoe-Chiba Band of 2, this yields a final DTW distance of 13 (d)
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included patients. Patients had a mean age of 50.9 years
(standard deviation [SD] = 15.4), and 165 were women
(64.7%). A bipolar disorder was diagnosed in 48 patients
(18.8%). The mean duration of illness was 11.2 ± 15
years. For 56 patients (22%), the current episode was the
first depressive episode. The baseline HRSD-17 score
was 20.7 (SD 4.6) on average, and 79.6% of the patients
used antidepressants. Of the 255 patients, 169 showed
treatment response and 128 remission at the end of ad-
mission. The median duration of hospitalization was 11
weeks, and the total number of assessments was 1480,
with a mean of 5.8 and a median of 5 HRSD-17 assess-
ments per patient.
Intra-individual approach
In Fig. 2, the DTW analyses of 2 exemplar patients are
shown. We will discuss these two exemplar patients in
order to demonstrate the opportunities of the DTW
clustering method to inform clinical practice. By com-
paring the results from patients 196 and 201, we can
already see a high degree of inter-individual variability in
symptom trajectories.
Patient 196 was a 55-year-old female presenting with
psychotic depression. At admission, anhedonia, insom-
nia, and psychic anxiety were overtly present. The anx-
ious preoccupations disabled her in engaging any
psychotherapy program at the start of hospitalization. A
treatment with electroconvulsive therapy (ECT) led to a
resolution of the most central symptoms (symptom with
most dense connections with other symptoms, e.g., de-
pressed mood, feelings of guilt, and somatic anxiety)
during the hospitalization of 2 months. Although she
remained to score relatively high on the HRSD-17 symp-
toms “work and interests,” “psychic anxiety,” and
“insight,” she could be discharged after the resolution of
the majority of her depressive symptoms. The central
(red) symptoms tended to fluctuate most strongly to-
gether over time. Furthermore, due to the presence of
residual symptoms that were resistant to ECT treatment,
we formulated an advice for ambulatory psychological
therapy to focus on these persistent (blue) symptoms of
insight, engagement in activities, and psychic anxiety as
a cornerstone of further treatment.
Patient 201 was a 38-year-old female who presented
with a severely depressed mood and suicidal thoughts.
She described her depressive complaints as an overpow-
ering sense of feeling down and agitated. There was no
loss of appetite or weight loss. A treatment with nortrip-
tyline and trazodone (for her sleeping problems, mainly
middle insomnia) was started. The sleeping problems
improved quickly. Her depressed mood and suicidal
thoughts did not change at the beginning of treatment.
Treatment with lithium, because of a suspicion of under-
lying bipolar disorder, led to a quick resolution of the mood
and anxiety symptoms. Loss of sexual interest was initially
not present but commenced during hospitalization, possibly
as a side effect of treatment.
Inter-individual approach
Figure 3 shows the nomothetic analysis of the 255 pa-
tients. A total of five clusters emerged, based on the
elbow method in the scree plot (see Fig. 3a). The hier-
archical cluster analysis was estimated based on the
average weighted distance matrix (Fig. 3b). These clus-
ters consisted of symptoms with a similar course trajec-
tory: (1) core symptoms (2 items: “depressed mood,”
“work and interests”), (2) sleep symptoms (3 items: late,
middle, and early insomnia), (3) distress (2 items: “guilt,”
“psychic anxiety”), (4) somatic symptoms (2 items: “geni-
tal symptoms,” “general somatic symptoms”), and (5)
inner turmoil (8 items: insight, weight loss, hypochon-
driasis, gastro-intestinal symptoms, somatic anxiety, agi-
tation, retardation, and suicide). As is shown in
Additional file 2: Fig. S1, the network plots did not
change significantly when excluding all symptoms with a
score of 0 throughout follow-up.
In the following step, we analyzed the actual 255 dis-
tance matrices, instead of one mean distance matrix,
using Distatis. Figure 3c shows the Distatis compromise
plot in which each HRSD-17 item is plotted according
to their first and second compromise factor values. The
distribution pattern of the HRSD-17 items in the com-
promise plot shows a comparable pattern to the ob-
tained hierarchical clusters, corroborating the obtained
five clusters. The clusters corroborated those found with
the hierarchical cluster analysis on the average distance
matrix. Next, the average distance matrix was visually
presented in a network graph in Fig. 3d.
Figure 4 shows the two centrality measures based on
the network from the average distance matrix. These
can inform us on which symptoms globally tend to co-
vary together over time. The items from the “inner tur-
moil” show the highest degree centrality and closeness
centrality scores, indicating that they covaried most
(See figure on previous page.)
Fig. 2 DTW analysis of HRSD-17 symptoms for patient no. 196 and patient no. 201 (a). Heatmap (symptoms that show high correlation are given
a “hot” red color, and those that are not correlated are given a “cold” blue color) (b). Dendrogram based on the clustering of DTW distances of
15 of the non-zero HRSD-17 item scores over time (c). Network graph based on the distance matrix: connections between symptoms (edges)
indicate distances between symptom trajectories (d). Centrality statistics of the network graph: centrality is based on the number and strengths
of connections each symptom has. Closeness also takes the global network structure into account (e)
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strongly with other HRSD-17 items. Items constituting
the “insomnia” or “somatic symptom” cluster showed
lower centrality which suggests that these symptoms be-
haved in a more independent manner over time com-
pared to the other HRSD-17 items.
The evolution of the mean HRSD-17 item levels over
time are visualized in Fig. 5a using mixed models per
item. The eight items with a range from 0 to 2 (three in-
somnia items: gastro-intestinal complaints, general som-
atic and genital symptoms, insight and weight loss) were
scaled to a range from 0 to 4 in order to make a com-
parability between all items possible. The HRSD-17
items “depressed mood,” “work and interests,” “general
somatic,” and “genital symptoms” had the highest base-
line severity. The items “insight” and “weight loss” had
the lowest mean scores and stayed relatively low during
hospitalization. Figure 5b shows the intercepts and
slopes of the 17 mixed models for the individual longitu-
dinal trajectories. The intercepts indicated that genital,
general somatic, and depressed mood symptoms gener-
ally scored the highest at baseline. The slopes of the lin-
ear model revealed that depressed mood showed the
steepest decline over time.
As shown in Fig. 6, patients that reached response or
remission during hospitalization had significantly shorter
average distances among symptoms than patients who
failed to reach response or remission. That is, patients
reaching response or remission mostly had on average a
more densely connected symptom network (based on
the mean DTW analysis). We excluded symptoms that
scored zero throughout the admission, yet when these
symptoms were included, this resulted in similar findings
(see Additional file 2: Fig. S2A). In addition, not adjust-
ing for HRSD-17 total scores at baseline did not alter
the results (see Additional file 2: Fig. S2B). Exploring the
difference in network connectivity between unipolar and
bipolar depressed patients revealed a denser symptom
network in bipolar than in unipolar patients (see Add-
itional file 2: Fig. S3).
Discussion
The present study is the first to analyze the time-series
of depression symptoms using DTW analyses in psychi-
atric inpatients. We applied the DTW computational
method to estimate and visualize similarities in symptom
trajectories and to yield clusters of symptoms with simi-
lar course trajectories both at the patient level and at the
group level. Both the intra- and inter-individual analyses
may help to increase our insight into the dynamical
complexity of symptom trajectories in severely depressed
inpatients. Furthermore, combining ROM techniques
with automated feedback for the clinician based on the
methods—as introduced here—proved useful to inform
Table 1 Characteristics and medication use of 255 consecutive
depressed inpatients
Variable Mean (SD)/no. (%)
Demographic characteristics
Female (%) 165 (64.7)
Bipolar disorder 48 (18.8)
Age in years, mean (SD) 50.9 ± 15.4
Educationa,b (n (%))
- Lower 41 (16.1)
- Intermediate 119 (46.7)
- Higher 93 (36.5)
Work status (n (%))
- Unemployed 149 (58.4)
- Employed 93 (36.5)
- Others (student/voluntary service) 13 (5.1)
Marital status (n (%))
- Married 109 (42.7)
- Divorced/widowed 65 (25.5)
- Never married 81 (31.8)
Living situationc (n (%))
- Living alone 76 (29.8)
- Living with partner 96 (37.6)
- Living with family 83 (32.5)
Clinical characteristics
Index (first) depressive episode (n (%)) 56 (22)
History of 4 or more depressive episodes (n (%)) 76 (29.8)
Lifetime substance abuse/dependencyd
- Alcohol 27 (10.6)
- Drugs (THC, hard drugs, benzodiazepines) 5 (2.0)
Melancholic features 159 (62.4)
ROM baseline total scores
- HRSD-17 20.7 ± 4.6
- BDI-II 33.7 ± 9.2
Baseline medication use
- Antidepressants 203 (79.6)
- Antipsychotics 118 (46.3)
- Mood stabilizers 34 (13.3)
Responders (%) 169 (66.3)
Remitters (%) 128 (50.2)
Data are mean (SD) or no. (%), when appropriate
ROM routine outcome monitoring, HRSD-17 17-item Hamilton Rating Scale for
Depression, BDI-II Beck Depression Inventory
aLower education, general basic education only; intermediate education,
middle vocational education; and higher education, higher vocational
education or university
bTwo missing values for education
cLiving alone includes living in a home for the elderly and the convent
dInvestigated using the MINI modules on substance abuse and suicidality
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and facilitate clinical decision making. Overall, three
major findings are worth discussing in more detail.
We first focused on the individual symptom dynamics
that proved to be highly variable across individuals and
thus idiosyncratic [41]. This finding supports previous
concerns on the use of sum scores for assessing treat-
ment outcome, since sum scores do not represent this
dynamical symptom complexity well [4, 16], with a loss
of substantial information that may be of clinical
relevance. The intra-individual dynamic symptom clus-
ters and symptom networks, in which the edges between
symptoms represented the dynamical relation between
them, allowed us to gain insight into the relative import-
ance of certain symptoms for individual patients, but
also at the group level [40]. Such symptoms may cause
other symptoms, which may be different for other pa-
tients [9]. It could be hypothesized that targeting treat-
ment on such central symptoms early in therapy may
Fig. 3 Nomothetic analyses based on all distance matrices from 255 depressed inpatients (see accompanying PDF). The scree plot displays the
eigenvalues in a downward curve. The number of factors was determined using the elbow method (i.e., the point where the slope of the curve is
leveling of; in our example, this is 5: after this point, the slope of the curve is nearly stable) (a). Ward’s (D2, i.e., general agglomerative hierarchical
clustering procedure) clustering criterion on the weighted mean distance matrix from 255 patients (b). Distatis analysis: the PCA of the
compromise matrix (i.e., weighted average of individual cross-product matrices) gives the position of the objects in the compromise space (c).
Overview of the networks of HRSD-17 items for 255 patients (d)
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lead to a more rapid resolution of closely connected de-
pressive symptoms [42, 43].
Overall, the study of intra-individual temporal dynam-
ics of depression symptoms is rare in the literature. A
growing field of research has focused on the develop-
ment of individual dynamic networks of symptoms in
which time-series or experience sampling methods
(ESM) data are used to study the within-patient dynam-
ical structure of symptoms [43–47]. These networks are
mostly estimated using vector autoregression (VAR)
which estimates both lagged (i.e., time minus one tem-
poral) and contemporaneous (i.e., simultaneous) rela-
tionships among multiple symptoms [45]. The DTW
approach represents a less constraint analysis of individ-
ual symptom dynamics since the DTW distance measure
accounts for a longer time period when measuring the
similarity between each pair of depressive symptoms (2
time points). Furthermore, it provides an accessible and
easily interpretable method that can be a useful tool for
clinicians and researchers for the early detection of cen-
tral symptoms and the directed tailoring of treatment to-
wards these symptoms. Moreover, it does not necessitate
the time-consuming ESM data collection, which can be
challenging in daily clinical practice due to the consider-
able burden it puts on participants.
Secondly, we focused on the group-level analyses,
which yielded five symptom clusters with more similar
dynamics over time across the total sample. Compared
to cross-sectional factor analytic studies, which investi-
gate the co-occurrence of depressive symptoms at a cer-
tain time point, we similarly found that the three sleep
items appeared consistently in one factor [20, 21]. Previ-
ously, there was some support for the presence of a
“general depression,” with depressed mood, guilt, sui-
cide, work and interests, and psychic anxiety appearing
on one factor [20–22]. We, however, found that only
“depressed mood” and “work and interest” showed the
most consistent trajectories over time, which repre-
sented the core symptoms of depression. Somatic symp-
toms did not appear on the same factor as described for
cross-sectional factor analyses (“somatic symptom” or
“somatized depression” consisting of somatic symptoms,
weight loss/gastro-intestinal symptoms, loss of libido/
genital symptoms) [20, 22]. Moreover, previous studies
found evidence for limited longitudinal invariance,
where the number of factors did not hold across time
Fig. 4 Centrality measures. The closeness centrality is the inverse of the average length of the shortest path between the focal node and every
other node in the network (i.e., the more central a node is, the closer it is to all other nodes). Degree centrality represents the connectivity, based
on the number and strengths of edges connected to it
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Fig. 5 Forest plot of the 17 HRSD items of two mean levels of indicators of individual longitudinal trajectories. The mixed model intercept (a)
indicates which symptoms scored the highest at baseline (i.e., genital, general somatic symptoms, and depressed mood scored the highest at
baseline). The mixed model slope (b) of the linear model showed the average decline per 2-week time interval (i.e., depressed mood showed the
steepest decline over time)
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[24, 48] which is supported by our and previous data
that the Omegas and Cronbach’s alphas were not stable
over time, but improved during hospital admission [49].
An internal validation of our findings using a random
sample of 128 and 127 patients of our sample revealed
the same dynamical clusters (see Additional file 2: Fig.
S4). Further validation of these findings in an independ-
ent sample is necessary.
Third, we found that patients who reached response
or remission during hospitalization had a more densely
connected symptom network compared to patients that
failed to reach response or remission. This contrasts
with the findings of Van Borkulo et al. [50], who identi-
fied a more densely connected cross-sectional depression
symptom network in not remitters compared to patients
reaching remission. Although the method of quantifying
network connectivity was not the same (average DTW
distance versus network comparison test), this shows,
once again, the importance of studying longitudinal net-
works besides cross-sectional symptom networks. Our
findings could be related to the literature reviewed by
Scheffer [51], showing that networks with high connectiv-
ity can change more abruptly (for better and worse) in re-
sponse to external events (so-called critical transitions).
Applied on the DTW network analysis, when symptoms
have a low level of connectivity, they seem to behave more
independently from each other and in response to an ex-
ternal factor such as admission and treatment, which may
have lowered the probability of an acute response or re-
mission to treatment. These findings need to be confirmed
in further studies, as the definition of response and remis-
sion was also based on the HRSD sum scores, which is
not independent of the DTW assessments from HRSD
time-series data.
The DTW method has a promising potential for clin-
ical practice, and it builds further upon the already avail-
able evidence of the value of measurement-based care in
psychiatry [52]. First, the DTW symptom clusters allow
the clinician to gain insight into the dynamics of individ-
ual depression symptoms and longitudinal symptom
clusters. Second, as illustrated in the two idiographic
analyses (Fig. 2), the DTW method has the potential to
facilitate clinical decision making. More specifically,
treatment interventions targeted at the most central
symptom (i.e., symptoms with the most dense connec-
tions with other symptoms) could lead to a rapid reso-
lution of the depressive syndrome. Third, the graphical
representation of the DTW clusters is easily amenable as
Fig. 6 Average DTW distance according to response and remission. Those patients with response or remission had the shortest average distance
among symptom trajectories, indicating denser interconnections (p by Wilcoxon signed-rank test to compare the two samples). Distances were
adjusted for the number of assessments and the baseline total HRSD-17 score
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a feedback tool for patients to gain more insight into the
central symptoms that tend to covariate with a variety of
other symptoms or in symptom clusters that tend to
move in a more independent matter. This could lead to
a more nuanced insight in reaching response or remis-
sion or lack thereof.
An important strength of our study is the use of the
innovative DTW clustering method to study the time-
series of individual symptom severity scores. The DTW
method is able to process the highly dimensional ROM
time-series data in order to reduce the complexity of the
data while still maintaining the essential characteristics
of the dataset. By using an elastic measurement, DTW
provides an optimal time alignment between two time-
series. Furthermore, DTW can be accurately used in
smaller datasets and individual patients [31]. Another
strength of our study is the relatively complete dataset of
ROM data from real-world consecutive inpatients. None-
theless, our results must be considered in light of some lim-
itations. First, exclusively inpatients were recruited from
one center which may limit the generalizability of our re-
sults to outpatients and other patient groups. Second, pa-
tients were treated with a variety of different combinations
of psychotropic drugs which likely affected the course and
dynamical characteristics of individual symptoms (such as
concentration difficulties in those receiving ECT). Future
studies using data from randomized trials may help to un-
ravel the influence of different treatment strategies on the
dynamic symptom dimensions. Third, the HRSD-17 is not
designed to investigate individual symptoms, and its items
are scored on a crude scale with only three or five answer
categories resulting in low variability and precision. Fourth,
assessments were done with 2-week intervals, and DTW
analyses may be more useful in more frequent time-series
like those collected with ESM. Fifth, the DTW method al-
lows some flexibility in how it is applied to study MDD
symptom trajectories, e.g., in terms of the global constraint
(Sakoe-Chiba Band). We adopted default settings based on
simulation studies in the prior literature and hope that fu-
ture methodological studies working with psychiatric data
specifically will investigate how robust empirical results are
to changes in default settings of the DTW method, e.g.,
using multiverse analyses [53].
Conclusion
MDD is a heterogeneous disorder consisting of dynamic
symptom clusters that varied between patients. The use
of repeated, standardized clinical rating scales yields ex-
tensive information on patient-specific symptoms dy-
namics. DTW may be a promising new methodology for
the study of the complex dynamic system of interacting
psychiatric symptoms [9, 15, 54] with the potential to fa-
cilitate personalized psychiatry care.
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Additional file 2: Figure S1. Network plots based on the DTW analyses
in the 255 patients. We compared the network structure based on all
data from all patients, and the analyses based only on symptoms that did
not score as 0 throughout the follow-up. Such symptom pairs with scores
of 0 will result in a distance of 0, solely because they were absent in
some patients. Figure S2. Average DTW distance according to response
and remission, including symptoms that scored zero throughout the
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231 of the 255 patients, who had a clinical diagnosis of either MDD of
BD. We compared the network structure [A and B] and calculated the
mean distance only on symptoms that did not score as 0 throughout the
follow-up. Although the network structure was largely similar, on average
patients with BD had a denser distance matric than patients with MDD
(P=0.0028). Figure S4. Network plots of two subsamples [A and B] of
the 255 patients. We used an automated split with a subset of 128 and
127 patients, in which we conducted separate DTW analyses. Node place-
ment was done by using the Procrustes algorithm (from the R Package
‘networktools’), to aid the visual comparison between the two networks.
As a result, configurations were brought into a similar space in which sta-
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